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ABSTRACT 
 
Integral membrane proteins are prone to 
aggregation and misfolding in aqueous 
environments and therefore require binding by 
molecular chaperones during their biogenesis. 
Chloroplast signal recognition particle 43 
(cpSRP43) is an ATP-independent chaperone 
required for the biogenesis of the most abundant 
class of membrane proteins, the light-harvesting 
chlorophyll a/b-binding proteins (LHCPs). 
Previous work has shown that cpSRP43 
specifically recognizes an L18 loop sequence 
conserved among LHCP paralogs. However, how 
cpSRP43 protects the transmembrane domains 
(TMDs) of LHCP from aggregation was unclear. 
In this work, alkylation-protection and site-
specific crosslinking experiments found that 
cpSRP43 makes extensive contacts with all the 
TMDs in LHCP. Site-directed mutagenesis 
identified a class of cpSRP43 mutants that bind 
tightly to the L18 sequence but are defective in 
chaperoning full-length LHCP.  These mutations 
mapped to hydrophobic surfaces on or near the 
bridging helix and the β-hairpins lining the 
ankyrin repeat motifs of cpSRP43, suggesting that 
these regions are potential sites for interaction with 
the client TMDs. Our results suggest a working 
model for client protein interactions in this 
membrane protein chaperone. 
 
 
Proper protein folding and localization are 
critical for cellular protein homeostasis. The post-
translational targeting of integral membrane proteins 
poses an acute challenge to protein homeostasis. 
Before arrival at the target membrane, nascent 
membrane proteins are highly prone to aggregation in 
the cytosol and other aqueous cellular compartments. 
Thus, effective molecular chaperones or chaperone 
networks are required to minimize improper exposure 
of the transmembrane domains (TMDs) on newly 
synthesized membrane proteins and to maintain them 
in a soluble, translocation-competent conformation. 
Many examples illustrate the intimate link between 
chaperone function and membrane protein biogenesis, 
including SecB, Skp, and SurA that protect bacterial 
outer membrane proteins, and Hsp70 homologues 
implicated in the import of precursor proteins to the 
endoplasmic reticulum, mitochondria or chloroplast 
(1-7). 
The light-harvesting chlorophyll a/b-binding 
proteins (LHCP) comprise over 50% of the protein 
content on the thylakoid membrane of green plants 
and form the most abundant family of membrane 
proteins on earth (8).  LHCPs are nuclear encoded, 
initially synthesized in the cytosol, and imported 
across the chloroplast envelope in a largely unfolded 
state (8). In the chloroplast stroma, LHCPs are 
protected in a soluble ‘transit complex’ by the 
chloroplast signal recognition particle (cpSRP), 
comprised of the cpSRP43 and cpSRP54 protein 
subunits (9-12). Via interactions between the GTPase 
domains of cpSRP54 and its receptor cpFtsY, LHCPs 
are delivered to the Alb3 translocase and inserted into 
the thylakoid membrane (11,13-20). Previous work 
showed that the cpSRP43 subunit binds tightly to and 
quantitatively prevents the aggregation of multiple 
members of the LHCP family, and that it is necessary 
and sufficient to chaperone LHCPs (21,22). Although 
the chaperone activity of cpSRP43 is allosterically 
regulated by additional components in the cpSRP 
pathway, such as cpSRP54 and Alb3 (19,22-24), the 
simple composition of the cpSRP43-LHCP 
chaperone-client pair and the robustness of 
cpSRP43’s chaperone activity make this pair an 
excellent system to understand the interaction and 
regulation of membrane protein chaperones.  
 A long-standing question about the cpSRP43 
chaperone is the mechanism by which it prevents the 
hydrophobic TMDs on its substrate proteins from 
aggregation. The substrate-binding domain (SBD) of 
cpSRP43 is comprised of ankyrin repeat motifs 1-4, 
capped at the N-terminus by a chromodomain (CD1) 
and at the C-terminus by a bridging helix (BH) 
(21,22,25). Biochemical and crystallographic 
analyses showed that a conserved Tyr204 in the third 
ankyrin repeat motif recognizes an FDPLGL motif in 
L18, a conserved 18-amino acid sequence between the 
second and third TMDs of LHCP (12,22,25-27). 
However, interaction with a soluble loop sequence is 
unlikely to be sufficient to protect LHCPs, which 
contain three TMDs, from aggregation. The ability of 
cpSRP43 to quantitatively prevent full-length LHCPs 
from aggregation is highly suggestive of additional 
interactions between cpSRP43 and the substrate 
TMDs. Moreover, a recent study showed that 
cpSRP43 also protects aggregation-prone regions of 
glutamyl-tRNA reductase to enhance the stability of 
this enzyme (28), indicating that cpSRP43 can contact 
hydrophobic segments on client proteins 
independently of L18 recognition. Nevertheless, 
deletion of individual TMDs in LHCP or replacement 
with the TMDs from unrelated membrane proteins did 
not severely disrupt the cpSRP43-LHCP interaction 
 at CA
LIFO
RN
IA
 IN
STITU
TE O
F TECH
N
O
LO
G
Y
 on A
pril 23, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Interactions in A Membrane Protein Chaperone 
3 
 
(26); this lack of specificity rendered the putative 
TMD interactions of cpSRP43 particularly 
challenging to demonstrate and identify. Although a 
crosslinking study identified three additional residues 
in TM3 of LHCP that can crosslink to cpSRP43 (27), 
the study did not identify additional possible 
interactions with the remainder of LHCP, nor the sites 
on cpSRP43 that interact with the substrate protein. 
Further, conformational rearrangements occur in the 
cpSRP43 SBD upon substrate binding (22), making it 
particularly challenging to define the interaction of 
this chaperone with the substrate TMDs.  
In this work, we used a combination of 
chemical modification-protection, crosslinking, and 
site-directed mutagenesis studies to understand the 
interaction between cpSRP43 and its client protein. 
The results showed that cpSRP43 can interact with 
LHCP across all three TMDs, and identified a set of 
mutant cpSRP43s that are specifically disrupted in 
their ability to chaperone LHCP without affecting 
recognition of the L18 motif. These observations 
suggest potential sites for TMD interactions on this 
membrane protein chaperone.  
 
RESULTS  
Mapping the interaction sites of cpSRP43 on Lhcb5 
through alkylation protection and site-specific 
crosslinking. Lhcb5 is a member of the LHCP family 
that strongly depends on cpSRP for its biogenesis. 
Previous work showed that Lhcb5 forms a tight 
complex with cpSRP43, with an apparent Kd value of 
~10 nM (26). To define the sites on Lhcb5 involved in 
complex formation with cpSRP43, we tested the 
ability of cpSRP43 to protect individual residues in 
Lhcb5 from alkylation by N-ethylmaleimide (NEM). 
To this end, we purified a set of Lhcb5 variants in 
which single cysteines were engineered at every 5-10 
residues across the entire sequence of Lhcb5 (29). To 
ensure that all Lhcb5 are bound by the chaperone, we 
tested the efficiency of complex formation between 
each single cysteine variant of Lhcb5 and cpSRP43 
(Table 1) and used cpSRP43 concentrations that are 
saturating for each Lhcb5 mutant during assembly of 
the respective cpSRP43•Lhcb5 complexes. The 
previously identified FDPLGL interaction motif in the 
L18 sequence was not tested, as point mutations at any 
of these residues severely impaired complex 
formation with cpSRP43 (25,26). 
 The efficiency of NEM alkylation was 
quantified by intact mass spectrometry and provides a 
direct measure for the solvent accessibility of 
individual cysteine residues in Lhcb5 (29). Previous 
work showed that LHCPs are imported into the 
chloroplast in a largely unfolded state (8), and its 
folding requires the lipids and binding of 
photosynthetic pigments in the thylakoid membrane 
(30-32). This loosely folded state of Lhcb5 in the 
stroma is mimicked by denaturation in 6M GdmCl or 
8M urea, and the NEM alkylation of the engineered 
single cysteines in denaturant solubilized Lhcb5 were 
used as a control to correct for the intrinsic differences 
in the reactivity of cysteines at different positions 
(29). Comparison of the alkylation efficiency in the 
cpSRP43•Lhcb5 complex to that of chemically 
denatured Lhcb5 provides a measure for the degree to 
which individual residues in Lhcb5 are protected by 
interaction with cpSRP43.   
 Representative data for the complexes of two 
Lhcb5 variants, V135C and E156C, are shown in 
Figures 1A and 1B, respectively. Deconvolution and 
quantification of the m/z spectrum showed that for 
Lhcb5(E156C), a single alkylated species was present 
after a 10 minute alkylation reaction, indicating that 
this site was fully alkylated and thus solvent exposed 
in the complex (Fig. 1B). By contrast, the m/z 
spectrum of Lhcb5(V135C) contained both the 
unalkylated and alkylated species (Fig. 1A), 
indicating that this site was protected by cpSRP43.  
  The results of the alkylation-protection 
experiments for all the Lhcb5 variants are shown in 
Figure S1 and summarized in Figure 1C. Mapping of 
the alkylation protection efficiencies at 10 minutes 
onto the sequence of Lhcb5 (Fig. 1D) revealed several 
patterns. Residues 70–143, which span the first two 
TMDs of Lhcb5 and their intervening loop, were 
modestly to heavily protected, suggesting that they 
were contacted by cpSRP43 in the cpSRP43•Lhcb5 
complex. Residues 190–200, which form the C-
terminal part of TM3, were also extensively protected, 
consistent with the results of a previous crosslinking 
analysis (27). The C-terminal loop of Lhcb5 was also 
modestly protected. In contrast, residues in the N- 
terminal loop of Lhcb5 were highly accessible. In 
addition, residues in the loop connecting TM2 and 
TM3 of Lhcb5 were accessible, consistent with 
crystallographic analysis showing that the L18 
peptide is bound at a solvent accessible site on the 
surface of cpSRP43 (25). Together, these results show 
that cpSRP43 induced protections of Lhcb5 including 
all its TMDs, the TM1-TM2 loop, and the C-terminus.   
  To independently probe for the interaction of 
the LHCP TMDs with cpSRP43, we incorporated a 
photoinducible crosslinker, p-benzoyl-L-
phenylalanine (pBpa), into specific positions of Lhcb5 
via amber suppression coupled to the S30 in vitro 
translation system (33-35). Crosslinking occurs when 
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the ketone oxygen of the incorporated pBpa is within 
3.1 Å of an interaction partner (36). To specifically 
examine the interactions between cpSRP43 and 
Lhcb5, we used a superactive mutant of cpSRP43 
(intein-cpSRP43) that has been shown to mimic the 
conformation and activity of cpSRP54-activated 
cpSRP43 in both NMR spectroscopy and biochemical 
assays (22). We observed UV-induced, cpSRP43-
dependent high molecular weight crosslinking 
products for pBpa incorporated at all three TMDs as 
well as the L18 motif of Lhcb5 (Fig. 2). Western blot 
analyses with anti-Strep (for Lhcb5) and anti-
cpSRP43 antibodies of both the in vitro translation 
reaction and affinity-purified cpSRP43-Lhcb5 
complex confirmed that the high-molecular weight 
band(s) contained both cpSRP43 and Lhcb5 (Fig. 3, 
A-C). MS analysis of the crosslinked bands for two 
Lhcb5 variants, with Bpa incorporated at residues 162 
and 180, further confirmed that both bands contained 
cpSRP43 and Lhcb5 at a roughly 1:1 molar ratio (Fig. 
3, D-F). These results indicate that all three of the 
TMDs of Lhcb5 can come into close contact with 
cpSRP43 in the complex. Crosslinking efficiency was 
highest with pBpa incorporated near the DPLG motif 
in the L18 sequence (Figs. 2, residues 162 and 164), 
consistent with specific recognition of this motif by 
cpSRP43. In comparison, the crosslinked bands 
between cpSRP43 and pBpa incorporated in the 
TMDs of Lhcb5 were weaker and more diffuse. The 
observation of two crosslinked bands, both containing 
equimolar cpSRP43 and Lhcb5 (Fig. 3D-F), further 
suggest the presence of alternative conformations in 
the cpSRP43-Lhcb5 complex.  These observations 
suggest that the interactions of Lhcb5 with cpSRP43 
are potentially dynamic.   
  Collectively, the combination of crosslinking 
and alkylation protection experiments in this section 
provides strong evidence that, in addition to the L18 
motif, cpSRP43 can make contacts with and induce 
protection of all three of the TMDs in its client 
protein. 
 
cpSRP43’s substrate binding domain is highly 
sensitive to point mutations. Previous work 
established that CD1, the ankyrin repeat motifs, and 
the BH together form a structural and functional unit 
that comprises the SBD of cpSRP43, which is 
sufficient to chaperone LHCPs (22). To establish 
which sites of cpSRP43 are involved in complex 
formation with LHCP, we mutated all solvent-
exposed hydrophobic residues (Leu, Ile, Val, and Trp) 
in the SBD, as well as additional residues on the β-
hairpins of the ankyrin repeat motifs and on the BH 
(highlighted in blue in Fig. 4A). Each residue was 
mutated to cysteine in an otherwise cysteineless 
cpSRP43 (C118A, C240S). Cys-less cpSRP43 is 5-
fold reduced in binding and chaperoning LHCP 
compared to wildtype cpSRP43 because it is shifted 
to a less active conformation (22), but otherwise 
behaves analogously to wildtype cpSRP43.  
 We tested each single cysteine mutant of 
cpSRP43 for its ability to bind and protect LHCP from 
aggregation using a well-established light scattering 
assay (Figs. 4B and 4C). In this assay, LHCP 
denatured and solubilized in 8M urea was added to a 
solution containing either buffer, cys-less cpSRP43 
(referred to as WT), or the mutant cpSRP43 of 
interest, and the turbidity of the solution was 
monitored in real time. In the absence of cpSRP43, 
LHCP aggregated extensively in aqueous solution 
(Figs 4B and 4C, green lines). The presence of 2.5 µM 
cys-less cpSRP43 prevented the aggregation of ~55% 
LHCP (Figs. 4B and 4C, black lines); this cpSRP43 
concentration thus provides the most sensitive 
condition to screen for mutant cpSRP43s defective in 
chaperone activity.  
 We found that single point mutations of a 
surprisingly large number of residues in the cpSRP43 
SBD compromised its chaperone activity. Of the 33 
single cysteine mutants tested, only 10 mutants 
exhibited chaperone activities within three-fold of that 
of cys-less cpSRP43 (Fig. 4B and 4D). Six mutants 
exhibited 3-5 fold reductions in the solubilization of 
LHCP compared to cys-less cpSRP43, and chaperone 
activity was undetectable for 17 mutants (Fig. 4C and 
4D). The sites of mutations that induced modest or 
severe defects in chaperone activity span almost an 
entire surface of the cpSRP43 SBD (see Fig. 8 below). 
Thus, cpSRP43 is highly sensitive to conservative 
perturbations in its SBD. 
To independently test the chaperone activity 
of cpSRP43 mutants, we used an alternative 
sedimentation assay (21). LHCP denatured in 8M urea 
was added to either cys-less (WT) or mutant 
cpSRP43, and the mixture was separated into soluble 
and insoluble fractions by sedimentation followed by 
analysis on SDS-polyacrylamide gel electrophoresis 
PAGE (Fig. 5A). Qualitatively, most mutants 
displayed changes in chaperone activity in the 
sedimentation assay (Fig. 5B) that are consistent with 
the results of the turbidity assay. Nevertheless, a 
smaller mutational defect was observed in the 
sedimentation assay compared to the turbidity assay 
(cf. Fig. 5B versus 4D). Control experiments with a 
number of mutants for which this discrepancy is most 
pronounced revealed two major contributing factors: 
 at CA
LIFO
RN
IA
 IN
STITU
TE O
F TECH
N
O
LO
G
Y
 on A
pril 23, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Interactions in A Membrane Protein Chaperone 
5 
 
(i) the higher protein concentration used in the 
sedimentation than the turbidity assay, which 
provided a more favorable binding equilibrium for 
cpSRP43 variants with binding defects (Fig. 5C); (ii) 
even at the same protein concentrations, the 
sedimentation assay showed a smaller mutational 
defect compared to the light scattering assay (Figs. 4D 
and 4E). This is likely due to less accurate 
quantification in western blot analysis, especially for 
mutants with large defects (the band in either the 
soluble or pellet fraction is outside the linear range of 
quantification). Thus, the sedimentation assay 
corroborated the defects of many cpSRP43 variants in 
chaperone activity, but the light scattering assay 
allowed a more sensitive and accurate detection of 
mutational defects. 
 Previous work showed that the ability of 
cpSRP43 to bind LHCP and generate a soluble transit 
complex is integral to the subsequent targeting and 
insertion of LHCP (10-14,37); this was the case for 
both in vitro translated as well as chemically 
denatured LHCP (21,38). To further assess the 
relationship between the ability of cpSRP43 to 
solubilize LHCP and the efficiency of LHCP targeting 
and integration, we measured and compared the two 
activities in parallel. LHCP unfolded in 8 M urea were 
either prevented from aggregation by dilution into a 
solution containing cpSRP43 (Fig. 6A, lane 1), or 
allowed to aggregate by dilution into buffer (Fig. 6A, 
lane 2). As cpSRP43 is also able to reverse LHCP 
aggregation (21,26,39), preformed LHCP aggregates 
were also incubated with increasing concentrations of 
cpSRP to allow re-solubilization by the chaperone 
(Fig. 6A, lanes 3-5). These samples were tested for the 
extent of LHCP solubilization (by the sedimentation 
assay) and for the efficiency of LHCP integration into 
thylakoid membrane (Fig. 6). Successful integration 
leads to protection of LHCP from thermolysin, giving 
rise to two protease-protected bands (Fig. 6A, DP1 
and DP2). We observed a strong correlation between 
the degree of LHCP solubilization by cpSRP43 and 
the efficiency of LHCP insertion (Fig. 6B). As a 
constant amount of targeting factors (cpSRP43, 
cpSRP54, and cpFtsY) was present in all the 
integration reactions regardless of the conditions of 
pre-incubation, the observed differences in LHCP 
integration efficiency do not arise from the differences 
in the concentration of targeting factors, but rather 
from differences in the conformation of LHCP prior 
to initiation of the integration reaction. Together with 
previous work(10-14,37), these results strongly 
suggest that the ability of cpSRP43 to solubilize 
LHCP is required for its proper targeting and 
integration into the thylakoid membrane. 
 
Two distinct classes of defective cpSRP43 SBD 
mutants. The large number of surface residues that 
exhibit a mutational defect in substrate binding could 
arise from an extensive interaction surface of 
cpSRP43 with LHCP, or from perturbations of the 
global conformation of the SBD by the mutations. 
Recent NMR studies showed that the SBD of apo-
cpSRP43 intrinsically samples active and inactive 
conformations with equal probability (22), supporting 
the possibility that the activity of cpSRP43 could be 
susceptible to mutations that shift the conformational 
equilibrium. To control for mutational effects on the 
global conformation of the SBD, we tested the ability 
of cpSRP43 mutants to bind the L18 recognition motif 
of LHCP. All the chaperone-defective mutations 
examined here are located away from the 
crystallographically identified L18 binding site of 
cpSRP43 (Y204 highlighted in Fig. 8 below; (25)); 
thus, a defect in L18 binding caused by these 
mutations most likely arises from a global structural 
defect of the SBD, rather than disruption of a direct 
interaction with L18.   
 The binding affinity of cpSRP43 for L18 was 
measured based on the cpSRP43-induced increase in 
the fluorescence anisotropy of a HiLyte-Fluor488-
conjugated L11 peptide, which represents the minimal 
sequence in L18 required for high affinity binding to 
cpSRP43 (26,29). Representative equilibrium 
titrations for L11-cpSRP43 binding are shown in 
Figures 6A and 6B. The equilibrium dissociation 
constants (Kd) for L11 binding to WT and mutant 
cpSRP43’s derived from the equilibrium titrations are 
summarized in Table 2. The anisotropy change of L11 
induced by a sub-saturating concentration (0.19 µM) 
of each mutant cpSRP43 relative to that of WT 
cpSRP43 are summarized in Figure 6C.  
 We found that mutation of a large number of 
residues affected the interaction of cpSRP43 with the 
L18 motif.  Eight mutants bound the L11 peptide an 
order of magnitude more weakly than WT cpSRP43 
(Kd ~ 0.8 –3.5 µM; Fig. 7B and Table 2, yellow), and 
three mutants exhibited ~100-fold weakened binding 
to L11 (Kd > 10 µM; Table 2, red). In contrast, eleven 
mutant cpSRP43s bound the L11 peptide with Kd 
values within 5-fold of that of WT cpSRP43 (Kd  < 0.6 
µM; Fig. 7A and Table 2, green). We designated ten 
of these mutants as Class I: they either bind L11 with 
similar affinity compared to WT cpSRP43 but are 
defective in chaperoning LHCP (L103C, W106C, 
V124C, L228C, I237C, N260C, and E263C), or the 
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modest reductions in L11 binding observed with these 
mutants were insufficient to account for their 
complete loss of chaperone activity towards LHCP 
(V156C, G193C, L231C). Thus, Class I mutants 
specifically disrupt the ability of cpSRP43 to protect 
LHCP from aggregation. The remainder of the 
chaperone-defective mutants were designated as 
Class II. Although a direct involvement in TMD 
binding cannot be excluded, much of the defects of 
these mutants can be attributed to disruptions in 
interaction with the L18 motif. Since these mutations 
are located away from the vicinity of the L18 binding 
site, Class II mutants disrupt L18 binding 
allosterically by altering the conformation of the SBD.   
 
DISCUSSION 
 cpSRP43 is a small, ATP-independent 
chaperone with an SBD comprised mostly of ankyrin 
repeat motifs. At a size of 25 kD, the cpSRP43 SBD 
is able to effectively chaperone multi-pass membrane 
protein substrates comparable to its own size, 
providing an attractive system to understand how a 
small protein scaffold interacts with and provides 
protection for large client proteins. Previous 
understanding of the cpSRP43-LHCP interaction was 
limited to recognition of the L18 loop sequence in 
LHCP by cpSRP43-Tyr204 (21,25,26,37). In this 
work, the results of alkylation-protection and 
crosslinking experiments showed that LHCP interacts 
more extensively with cpSRP43; the regions of 
interaction and/or cpSRP43-induced protection span 
all three TMDs of LHCP as well as the TM1-TM2 
loop and the C-terminus.  Furthermore, site-directed 
mutagenesis of the cpSRP43 SBD identified two 
classes of mutant cpSRP43’s: Class I, which disrupts 
cpSRP43’s ability to protect LHCP from aggregation 
without affecting high-affinity recognition of L18; 
and Class II, which allosterically disrupts binding of 
the L18 motif. Together, these results provide 
evidence for much more extensive cpSRP43-client 
interactions than previously recognized, and suggest 
potential sites of cpSRP43 that bind and protect the 
TMDs of LHCP. 
 When mapped onto the crystal structure of 
the cpSRP43 SBD, the two classes of mutants are 
enriched in different regions of the cpSRP43 SBD, 
suggesting that different surfaces in the SBD mediate 
distinct functions. The residues that give rise to Class 
II mutants are primarily located on the helices in the 
ankyrin repeat motifs (Fig. 8B, magenta). As the sites 
of Class II mutations are away from the previously 
identified L18 binding site (Tyr204; highlighted in 
blue), we attribute their defects to disruption of the 
active conformation of the cpSRP43 SBD (see 
discussion in the next paragraph). In contrast, residues 
that give rise to Class I mutants are enriched in the 
bridging helix, the β-hairpins in the ankyrin repeat 
motifs, and a hydrophobic surface in CD1 (Fig. 8A, 
orange), suggesting that these regions may either form 
or are in close vicinity of the TMD binding sites in 
cpSRP43. In support of this notion, Class I mutations 
cluster on or near major hydrophobic surfaces on the 
cpSRP43 SBD (Fig. 8C). This model is also consistent 
with the general structural and functional features of 
ankyrin repeat proteins, which are formed by 
individual repeats of helix-loop-helix folds connected 
by β-hairpins.  Structural, computational, and protein 
engineering studies showed that intra- and inter-repeat 
interactions between the helices allow ankyrin repeat 
proteins to cooperatively fold into concave L-shaped 
structures; in contrast, the loops and β-hairpins, which 
project outward from the helices, often form the 
recognition site for interaction partners (40-43). We 
therefore propose that client recognition by cpSRP43 
may occur analogously, with the L18 sequence 
specifically recognized by the loop in Ank3, while the 
TMDs in LHCP are bound and protected by the 
hydrophobic surfaces on Ank4 and BH, and on or near 
the β-hairpins.  
 The large number of residues in the cpSRP43 
SBD, at which a single conservative mutation away 
from the direct L18 interaction site severely disrupts 
substrate binding and chaperone activity, is 
extraordinary. This behavior is characteristic of 
molecular systems that sample inactive conformations 
with a high probability, such that small perturbations 
are sufficient to drive the molecule or complex into 
the inactive state (44-47). Likewise, the sensitivity of 
cpSRP43 to point mutations suggests that its SBD is 
at the threshold of a cooperative conformational 
change required to attain a chaperone-active 
conformation. This model is consistent with recent 
NMR data that detected distinct conformational states 
in the cpSRP43 SBD that are equally populated in 
apo-cpSRP43 (22). As observed previously, this 
property of cpSRP43 may be particularly useful in 
enabling regulation, allowing cpSRP43 to be readily 
switched ‘on’ and ‘off’ by its regulators in the stroma 
and at the target membrane, respectively (22). The 
precise nature of the conformational changes in 
cpSRP43 remains an important question for future 
investigations. 
 
EXPERIMENTAL PROCEDURES 
Protein Expression and Purification. Single cysteine 
mutants of Lhcb5 and cpSRP43 were constructed 
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using the QuikChange Mutagenesis procedure 
(Stratagene) according to manufacturer’s instructions. 
WT and mutant cpSRP43, LHCP, and wildtype and 
mutant Lhcb5 were overexpressed and purified as 
previously described (20,21). 
Alkylation. Single-cysteine mutants of Lhcb5 
solubilized in 8M urea was treated with 4 mM TCEP 
overnight. Lhcb5 was rapidly diluted to a final 
concentration of 1 µM in Buffer D (200 mM NaCl, 50 
mM KHEPES, pH 7.5) containing 4 µM cpSRP43 and 
incubated for 10 min to allow complex formation. The 
sample was centrifuged at 13,000 rpm for 30 min to 
remove aggregated proteins, and the soluble fraction 
was subject to NEM alkylation as described (29). 
Briefly, the pre-formed Lhcb5-cpSRP43 complex was 
incubated with 100 µM N-ethylmaleimide (NEM) for 
2 or 10 minutes and quenched with 50 mM DTT. 
Quenched samples were treated with 0.2% formic 
acid and analyzed on an LC-MSD SL 1100 series 
(Agilent) using a 2.1 x 150 mm Zorbax 300SB-C3 
column (Agilent) and a gradient consisting of 0.2% 
formic acid as solvent A and 0.2% formic acid in 
acetonitrile (89.8%) and methanol (10%) as solvent B. 
Intact masses were determined in the single 
quadrupole. Chemstation software (Agilent) was used 
to deconvolute the masses and quantify the proteins. 
The accessibility of each site (1- protection) was 
calculated from the alkylation efficiency of each 
cysteine mutant observed in the cpSRP43-Lhcb5 
complex after subtracting that of the same mutant 
denatured in 6M GdmCl. 
Photoinducible crosslinking. Amber stop codons 
were introduced into Lhcb5-coding plasmids at the 
indicated sites using the QuikChange Mutagenesis 
procedure (Stratagene). To incorporate pBpa, Lhcb5 
harboring the amber codon at specific positions were 
in vitro translated using an S30 translation extract 
coupled to amber suppression, as previously described 
(35), except that an evolved aminoacyl-tRNA 
synthetase specific for pBpa was used in place of that 
for coumarin (34). Translation reactions were 
incubated for 90 minutes at 30 °C in the presence or 
absence of 20 µM intein-cpSRP43. Crosslinks were 
induced by exposure to 365 nm light for 2 hours at 4 
°C. 10 µL reactions were mixed with an equal volume 
of 2X SDS and 4M Urea and analyzed by SDS-PAGE. 
Gels with 35S-labeled Lhcb5 were visualized by 
autoradiography using a Typhoon scanner. Western 
blots with 1XStrep-tagged Lhcb5 were 
immunoblotted with either anti-Strep or anti-
cpSRP43 antibodies and visualized on a LI-COR 
Odyssey imaging system at 800 nm. Bands were 
quantified using the GelAnalyzer software. 
Crosslinking efficiency was determined by the ratio of 
the high-molecular weight crosslinked Lhcb5 bands to 
total Lhcb5 after subtracting the cpSRP43-
independent crosslinks in the corresponding area in 
control reactions lacking cpSRP43. 
 To purify cpSRP43-Lhcb5 after crosslinking, 
translation reactions were scaled up to 1 mL and 
incubated for 60 minutes at 30 °C in the presence or 
absence of 5 µM intein-cpSRP43. Crosslinks were 
induced by exposure to 365 nm light for 45 min at 4 
°C. After centrifugation at 16,000g for 15 min, the 
supernatant was loaded onto 100 µL Strep-Tactin 
resin pre-equilibrated with Strep Wash Buffer (20 mM 
HEPES, 500 mM NaCl, pH 7.5), or 100 µL of NiNTA 
resin pre-equilibrated with NiNTA Wash Buffer (20 
mM HEPES, 300 mM KCl, 20 mM imidazole, pH 
7.5). The resin was washed five times with 500 µL of 
Strep or NiNTA Wash Buffer and eluted with 500 µL 
of Strep Elution Buffer (20 mM HEPES, 500 mM 
NaCl, 20 mM Biotin, pH 7.5) or NiNTA Elution 
Buffer (20 mM HEPES, 300 mM KCl, 200 mM 
imidazole, pH 7.5). The final wash and elution 
fractions from Strep-Tactin purification were 
immunoblotted with anti-cpSRP43 antibody as 
previously described. The wash and elution fractions 
from NiNTA purification were stained with 
Coomassie blue and sent for MS analysis.  
Mass spectrometry analysis of cpSRP43•Lhcb5 
crosslinks. Samples were separated by SDS-PAGE 
using a 4–12% gradient NuPAGE gel (Invitrogen) 
with NuPAGE MES running buffer (Invitrogen) for 
35 minutes at 200 V. The gel was stained with 
colloidal Coomassie stain (Invitrogen) and de-stained 
with water and ammonium bicarbonate. The desired 
bands were excised  and digested by trypsin overnight 
at 37 °C. Digested peptides were extracted from gel 
and lyophilized. Digested samples were subjected to 
LC-MS/MS analysis on a nanoflow LC system, 
EASY-nLC 1200 (Thermo Fisher Scientific) coupled 
to a QExactive HF Orbitrap mass spectrometer 
(Thermo Fisher Scientific, Bremen, Germany) 
equipped with a Nanospray Flex ion source. Samples 
were directly loaded onto a 20cm x 50µm ID PicoFrit 
column (New Objective, Woburn, MA) packed in 
house with ReproSil-Pur C18AQ 1.9 um resin (120A° 
pore size, Dr. Maisch, Ammerbuch, Germany) and 
heated to 60 °C. Peptides were separated with the 
following gradient at a flow rate of 220 nL/min: 2–6% 
Solvent B (3 min), 6-25% B (40 min), 25-40% B (17 
min), and 100% B (9min). Solvent A consisted of 
97.8% H2O, 2% ACN, and 0.2% formic acid, and 
solvent B consisted of 19.8% H2O, 80% ACN, and 
0.2% formic acid. The QExactive HF Orbitrap was 
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operated in data dependent mode with the Tune 
(version 2.7 SP1build 2659) instrument control 
software. Spray voltage was set to 2.5 kV, S-lens RF 
level at 50, and heated capillary at 275 °C. 
Raw files were searched against the protein 
sequences using MaxQuant (48,49) (ver. 1.6.0.16) 
assuming trypsin digestion with up to two missed 
cleavages. Precursor mass tolerances were less than 
4.5 ppm after mass recalibration and fragment ion 
tolerances were 20 ppm. Protein abundances were 
estimated by iBAQ (50).   
Chaperone Activity of cpSRP43. The ability of 
cpSRP43 to prevent LHCP aggregation was measured 
as described (21). cpSRP43 were ultracentrifuged in a 
TLA-100 rotor (Beckman Coulter) at 100,000 rpm for 
30 min at 4 °C prior to the experiment. Light 
scattering experiments were performed by addition of 
3 µL of 50 µM LHCP denatured in 8 M urea to 150 
µL buffer D (50 mM KHEPES, pH 7.5, 200 mM 
NaCl) or 2.5 µM cpSRP43 in buffer D. Assays at 
higher protein concentrations were performed by 
addition of 6 µL of 125 µM LHCP to 150 µL of 15 
µM cpSRP43. Light scattering was monitored at 360 
nm on a UV-Vis spectrometer (Beckman Coulter) 
over time until equilibrium was reached. The 
percentage of soluble LHCP (% soluble) at 300 s was 
calculated from: 
 % soluble =  1 – Aobsd / A0 
in which A0 and Aobsd are the optical density readings 
in the absence and presence of cpSRP43, respectively. 
cpSRP43 itself does not contribute to the optical 
density reading (21). 
 Sedimentation experiments were performed 
by addition of 1 µL of 100 µM LHCP denatured in 
8M urea to 19 µL of 15 µM cpSRP43 in buffer D. 
Sedimentation assays at lower concentrations were 
performed by adding 1 µL of 20 µM LHCP to 19 µL 
of 5 µM cpSRP43. The mixtures were incubated at 
room temperature for 30 minutes, and the soluble and 
pellet fractions were separated by centrifugation at 
18,000 g for 30 minutes at 4 °C. The pellet was 
resuspended in 8M Urea, and both the pellet and 
soluble fractions were analyzed by SDS-PAGE. Gels 
were stained with Coomassie Blue (when using 5 µM 
LHCP) or western blot using an anti-LHCP antibody 
(when using 1 µM LHCP), and were imaged on a LI-
COR Odyssey imaging system at 700 nm (for 
Coomassie stain) or 800 nm (for western blots). The 
intensity of LHCP bands was quantified using the 
GelAnalyzer software. 
Measurement of L18 binding. The L18 binding 
affinity of cpSRP43 was measured using L11 
(GSFDPLGLADD), the minimal binding motif in 
L18, conjugated to HiLyte-Fluor488. Anisotropy 
measurements were conducted in Buffer D on a 
Fluorolog 3-22 spectrofluorometer (Jobin Yvon), 
using 100 nM HiLyte-Fluor488-labeled L11 and 
varying concentrations of cpSRP43. Samples were 
excited at 500 nm and fluorescence anisotropy was 
recorded at 527 nm, as previously described (21,22). 
The data were fit to Eq 1, 𝐴"#$ = 𝐴& +∆𝐴 )** + ,-" +./0 ( )** + ,-" +./)304[)**][,-"]7[)**]      (1) 
in which [pro] is cpSRP43 concentration, Aobsd is the 
observed anisotropy value, A0 is the anisotropy value 
without cpSRP43, ∆A is the change in anisotropy at 
saturating cpSRP43 concentrations, and Kd is the 
equilibrium dissociation constant for the interaction of 
cpSRP43 with L11-HiLyte-Fluor488. 
LHCP Integration Assay. Thylakoids were collected 
from chloroplasts of 9-12 days old pea leaves (Laxton 
Progressive 9) hypotonically lysed in lysis buffer (10 
mM KHEPES, pH 7.5, 10 mM MgCl2) as described 
(51). Thylakoids were further salt-washed and 
resuspended to a concentration of 1 mg/mL 
chlorophyll (1X). Each 150 µL LHCP integration 
reaction contained 20 µL of 35S-methionine-labeled 
LHCP pre-incubated with cpSRP43 (generated as 
described in legends to Fig. 6), 50 mL of 1X salt-
washed thylakoid, 2 mM ATP, 2 mM GTP, 3 µM 
cpFtsY, and cpSRP43/54 supplemented to a final 
concentration of 3 µM. Integration reactions were 
incubated at 25 °C for 30 min and quenched on ice. 
The reaction mixtures were thermolysin-treated for 40 
min and centrifuged to isolate the thylakoid 
membrane as described (51). The resulting pellets 
were resuspended in 2X SDS and analyzed by SDS-
PAGE and quantified using Storm 840 (Molecular 
Dynamics) and ImageQuant (GE Healthcare). 
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Table 1. Chaperone activity of cpSRP43 towards individual Lhcb5 single-cysteine mutants (columns 2 and 3), 
and NEM alkylation efficiency at each cysteine in the presence of WT cpSRP43 (columns 4 and 5).   
 
Lhcb5 Construct 1 µM cpSRP43 
Activitya 
5 µM cpSRP43 
Activitya 
Alkylationb at 2’ Alkylationb at 10’ 
I40 ND ND 1.0 1.0 
G50 ND ND 1.0 1.0 
Q70 ND ND 0.55 ± 0.02 0.67 ± 0.10 
I75 84.48 ND 0.53 ± 0.05 0.66 ± 0.10 
A85 102.15 ± 0.66 ND 0.33 ± 0.00 0.39 ± 0.02 
P90 57.06 ± 31.69 ND 0.19 0.37 ± 0.14 
C100 (WT) 95.59 ND 0.62 ± 0.16 0.66 ± 0.17 
G110 ND ND 0.29 ± 0.05 0.35 ± 0.03 
N120 ND ND 0.47 ± 0.04 0.52 ± 0.09 
N125 74.62 ND 0.47 ± 0.00 0.56 ± 0.11 
L130 68.18 ± 0.24 ND 0.28 ± 0.00 0.32 ± 0.01 
V135 89.89 ± 14.78 ND 0.13 0.18 ± 0.01 
G143 89.20 ND 0.34 0.45 ± 0.01 
T150 95.84 ND 0.80 0.88 ± 0.03 
E156 80.74 ND 1.0 1.0 
D157 86.34 ND 1.0 1.0 
G162 95.39 ND 1.0 1.0 
A171 86.33 ND 1.0 1.0 
L180 89.85 ND 0.91 ± 0.12 0.91 ± 0.13 
I185 82.86 ± 5.02 ND 0.91 ± 0.12 0.86 ± 0.02 
L190 59.79 95.04 0.44 ± 0.10 0.48 ± 0.11 
M195 74.87 ± 23.58 95.50 0.17 ± 0.02 0.24 ± 0.05 
I200 77.24 ND ND 0.25 ± 0.10 
V210 92.27 ND 0.81 0.91 ± 0.13 
P220 88.82 ND 0.44 0.50 ± 0.17 
A230 87.60 ND 0.56 0.64 ± 0.14 
acpSRP43 chaperone activity was measured using 1 µM Lhcb5 in the light scattering assay. % soluble Lhcb5 at 
indicated cpSRP43 concentrations are reported. bFraction of NEM modified Lhcb5 in the cpSRP43•Lhcb5 
complex after indicated times of the alkylation reaction. All values represent mean ± S.E.M., with n = 2. N.D., 
not done. 
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Table 2. Kd values for binding of HiLyte-conjugated L11 to individual cpSRP43 mutants. All cpSRP43 
mutants shown in this table are derived from cys-less cpSRP43 (denoted as WT). Green highlights mutants 
that exhibit Kd values within 3-fold of WT cpSRP43; yellow highlights mutants exhibiting 3-5 fold defects in 
L11 binding; and red highlights mutants that are severely defective in L11 binding. * indicates that saturation 
could not be reached with the mutant during equilibrium titrations, and their Kd values for L11 were estimated 
assuming the same end point in the titration curve as cys-less cpSRP43. 
 
Construct Average Kd (µM) 
WT 0.12 ± 0.029 
L103C 0.14 ± 0.052 
W106C 0.19 ± 0.027 
W114C 3.03  ± 0.61 
V124C 0.18 ± 0.058 
V125C 0.78 ± 0.058 
W133C 17.5* ± 3.65 
V156C 0.55 ± 0.17 
T162C 12.2* ± 0.44 
F166C 3.53 ± 0.44 
G193C 0.53 ± 0.16 
G194C 2.38 ± 0.61 
L195C 14.8* ± 5.26 
T196C 0.87 ± 0.14 
V222C 0.83 ± 0.22 
L228C 0.083 ± 0.066 
L231C 0.41 ± 0.029 
I237C 0.17 ± 0.078 
L238C 2.05 ± 0.19 
R252C 0.42 ± 0.18 
E256C 0.64 ± 0.017 
I259C 0.94 ± 0.26 
N260C 0.062 ± 0.0035 
E263C 0.22 ± 0.063 
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Figure Legends 
 
Figure 1. Alkylation pattern of Lhcb5 in the cpSRP43•Lhcb5 complex show cpSRP43-induced protection on 
the substrate protein. (A, B) Mass spectrum (upper left), deconvolution (lower panels), and component analysis 
(upper right) for a partially alkylated Lhcb5 residue, C135 (part A) and a completely alkylated Lhcb5 residue, 
C156 (part B). (C) Summary of the NEM alkylation efficiencies at individual sites in Lhcb5. Alkylation 
reactions were carried out for 10 minutes.  For each engineered cysteine, ‘Fraction Accessible’ was calculated 
from the ratio of the fraction of alkylation in the cpSRP43•Lhcb5 complex relative to that of Lhcb5 dissolved in 
6M GdmHCl. Error bars indicate S.E.M., with n = 2. (D) The alkylation protection pattern of Lhcb5 in 
complex with cpSRP43 is mapped onto the sequence of Lhcb5. Colored triangles denote the extent of 
protection, with white denoting the least protection (0% protection, or 100% alkylation) and blue denoting the 
highest observed protection (>50% protection, or <50% alkylation). 
 
Figure 2. Site-specific crosslinking suggests extensive contacts between Lhcb5 and cpSRP43. (A) SDS-PAGE 
analysis of 35S-labeled Lhcb5 containing a photocrosslinker, pBpa, at indicated positions. Purified superactive 
cpSRP43 was present (+ lanes) or absent (– lanes) during translation, and samples were protected from light (– 
lanes) or exposed to UV light to induce pBpa crosslinks (+ lanes). Marked bands indicate the crosslinked 
cpSRP43•Lhcb5 complex (red), free Lhcb5 (green), and Lhcb5 crosslinked to an unknown protein in the 
translation extract (yellow). (B) Summary of crosslinking efficiencies between cpSRP43 and Lhcb5 with pBpa 
incorporated at different sites. Crosslinking efficiency was calculated from the ratio of the cpSRP43•Lhcb5 
band to total Lhcb5 (after subtraction of background from the corresponding locations in the +UV, –cpSRP43 
lane) for the SDS-PAGE analysis in part A and replicates (not shown). Data are reported as mean ± S.E.M, 
with n = 2. 
 
Figure 3. Analysis of the high molecular weight crosslinked bands between cpSRP43 and Lhcb5. The color-
marked bands in A-D indicate the crosslinked cpSRP43•Lhcb5 complex (red), free Strep-Lhcb5 (green), free 
cpSRP43 (blue), and Strep-Lhcb5 crosslinked to an unknown protein (yellow). (A-B) Representative western 
blot analyses of the crosslinking reactions and their controls from Figure 2A using anti-Strep (for Strep-tagged 
Lhcb5; part A) or anti-cpSRP43 (part B) antibodies. The lower MW band for Lhcb5 is likely a C-terminally 
proteolyzed product of full-length Lhcb5. (C) Representative western blot of affinity purification of the 
cpSRP43-Lhcb5 complex based on Strep-tagged Lhcb5. The final wash (W) and elution (E) from Strep-Tactin 
resin of Strep-Lhcb5 were shown for reactions with (+ lanes) and without (– lanes) intein-cpSRP43 and 
exposure to UV light. (D) Representative Coomassie-stained SDS-PAGE gels for the same crosslinking 
reactions purified based on His6-tagged cpSRP43, with Bpa incorporated at the indicated residues of Lhcb5. 
(E) NuPAGE gels showing the purified (as in C and D) cpSRP43-Lhcb5(162Bpa) and cpSRP43-
Lhcb5(180Bpa) crosslinking reactions. The two labeled bands (A and B) were digested and sent for mass 
spectrometry analysis. (F) Representative results for MS analysis of the abundance of cpSRP43 and Lhcb5 in 
bands A and B excised the gel in part E for Lhcb5(162Bpa). 
 
Figure 4. Single-cysteine mutants across the cpSRP43 SBD exhibit defects in chaperone activity in the light 
scattering assay. (A) Structure of cpSRP43 indicating all sites where cysteine mutations were made (blue). (B, 
C) Representative data showing the chaperone activity of neutral (part B) and defective (part C) cpSRP43 
mutants. Light scattering time traces are shown for LHCP diluted into aqueous buffer (green), into a solution 
containing cys-less WT (black), and into solutions containing the indicated cpSRP43 mutants. (D) Summary of 
the chaperone activity for all the single cysteine mutants of cpSRP43 measured by light scattering. Mutants 
exhibiting chaperone activity within three-fold of that of cys-less cpSRP43 are considered neutral (above 
dashed line), whereas mutants with lower activity are considered defective (below dashed line).  Error bars 
indicate S.E.M, with n = 3-13.  
 
Figure 5. Analysis of the chaperone activity of mutant cpSRP43 using the sedimentation assay and 
comparison with the results of light scattering assay. (A) Representative Coomassie-stained gels for analysis of 
the chaperone activity of cpSRP43 mutants using the sedimentation assay. ‘C’ denotes lanes with cpSRP43 
only; ‘S’ denotes the soluble fraction; ‘P’ denotes pellet. (B) Summary of the relative chaperone activity of all 
 at CA
LIFO
RN
IA
 IN
STITU
TE O
F TECH
N
O
LO
G
Y
 on A
pril 23, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Interactions in A Membrane Protein Chaperone 
11 
 
cpSRP43 mutants measured by the sedimentation assay. Values are reported relative to cys-less cpSRP43 
(WT). (C) Comparison of the chaperone activity of cpSRP43 mutants measured at high (green) and low (blue) 
protein concentrations using the light scattering assay. (D) Representative western blot images for analysis of 
the chaperone activity of cpSRP43 mutants using the sedimentation assay at low protein concentrations. ‘C’ 
denotes lanes with cpSRP43 only; ‘S’ denotes the soluble fraction; ‘P’ denotes pellet. ‘LHCP’ denotes controls 
where indicated concentrations of purified LHCP were loaded to assess the dynamic range of western blot. (E) 
Comparison of the chaperone activity of cpSRP43 variants measured by the sedimentation (red; data from part 
D and replicates) and light scattering (blue) assays at the same concentration.  Data were reported as mean ± 
S.E.M, with n = 2 – 9. 
 
Figure 6. Solubilization of LHCP by cpSRP43 correlates with LHCP targeting and integration. (A) 35S-
methionine labeled LHCP (lane 6, ‘Load’) were pre-incubated under different conditions with cpSRP43 and 
tested for targeting and insertion into thylakoid membrane in the presence of 3 µM cpSRP43, cpSRP54, and 
cpFtsY. Lanes 1-2: 2 µL of 35S-LHCP in 8 M urea was added to 40 µL Buffer D with (lane 1) or without (lane 
2) 3 µM cpSRP43/54 and incubated for 60 min. Lanes 3-5, 2 µL of 35S-LHCP in 8 M urea was added to 
33.6 µL of Buffer D and allowed to aggregate at RT for 60 sec, followed by addition of an equimolar ratio of 
cpSRP43/54 to final concentrations of 5, 15 and 30 µM in a final volume of 40 µL. 20 µL of the preincubated 
sample was used for the LHCP integration assay. DP1 and DP2 (25 and 18.5 kDa) are the protease-protected 
fragments of integrated LHCP (51). The remaining 20 µL was subjected to the sedimentation assay as 
described under Experimental Procedures, except that LHCP bands were quantified by autoradiography using 
Storm 840 (Molecular Dynamics) and ImageQuant (GE Healthcare). Details of the LHCP integration assay are 
described under Experimental Procedures. (B) Correlation of the translocation efficiency of LHCP with the 
degree to which LHCP is solubilized by cpSRP43. 
 
Figure 7. Characterization of the interaction of mutant cpSRP43s with the L18 motif. (A, B) Representative 
equilibrium titrations for the binding of WT and mutant cpSRP43s to Hylite-Fluor488 labeled L11.  
Representative data for cpSRP43 mutants that can bind L11 with high affinity are shown in part A, and those 
for mutants exhibiting weakened L11 binding are shown in part B. (C) Summary of the cpSRP43-induced 
changes in the fluorescence anisotropy of L11 at 0.19 µM, which is subsaturating for binding of cys-less 
cpSRP43 to L11.  The data for all mutants are normalized to that of cys-less cpSRP43 (denoted as WT).  All 
data are reported as mean ± S.E.M., with n ≥ 2. 
 
Figure 8. Mapping two classes of cpSRP43 mutants onto the crystal structure of the cpSRP43 SBD (PDB# 
3dep). (A) Residues whose mutations led to defective chaperone activity for LHCP but did not disrupt L18 
binding are categorized as Class I and colored in orange. (B) Residues whose mutations disrupted both 
cpSRP43’s chaperone activity and its interaction with the L18 motif are categorized as Class II and colored in 
magenta. (C) A putative model for the interaction surfaces of cpSRP43 with LHCP, with Tyr204 (blue) 
interacting with the L18 sequence, and the hydrophobic surfaces formed by Ank4, BH and the β-hairpins along 
the ankyrin repeat motifs involved in protection of the TMDs of LHCP. The electrostatic surface potential of 
the cpSRP43 SBD was generated using Adaptive Poisson-Boltzmann Solver (52) and visualized in PyMOL 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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